Cumberland Pharmaceuticals, Inc. (CPIX) Misses Q1 EPS by 3c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q1 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $12.87 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Jefferies Downgrades Belimo Holding AG (BEAN:SW) (BLHWF) to Hold
• Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy